Back to Test Catalogue

Broad Spectrum Drug Screen, Urine

Test ID: DS USTM

Test

Method

LC-QTOF (High-Resolution Mass Spectrometry)

Report Includes

The current list of drugs and/or metabolites analyzed and their corresponding limits of detection can be accessed here

Specimens

Urine

Clinical Utility

Broad-spectrum urine drug screening identifies a wide range of drugs of misuse and prescription drugs, Urine drug testing is indicated in many scenarios including 1) confirming opioid use at baseline; 2) ensuring adherence to medication; and 3) screening for unregulated drug use or identifying unexpected exposure during treatment.

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

14-Nov-2024

Specimen

Specimens

Urine

Collection Containers

Sterile Container

Sample Volume

5.0 mL

Minimum Volume

0.25 mL

Collection & Handling

Handling Information

Store and send cold.

Additional Information

Provision of expected drugs and/or suspected illicit drugs will assist analytical interpretation of results.

Stability

Ambient 4 hours
Refrigerated 30 days
Frozen 30 days

Test Version

14-Nov-2024

Performance / Interpretation

Method

LC-QTOF (High-Resolution Mass Spectrometry)

Turnaround Time

3 days

Test Location

St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8

Test Version

14-Nov-2024

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
DS USTM 64647Broad Spectrum Toxicology Screen (LC-MS), Urine

Test Version

14-Nov-2024